Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Can-Fite Biopharma Ltd ADR
(NY:
CANF
)
2.420
+0.040 (+1.68%)
Streaming Delayed Price
Updated: 3:42 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Can-Fite Biopharma Ltd ADR
< Previous
1
2
3
4
Next >
Can-Fite Completes Patient Enrollment in Phase III Psoriasis Study
September 02, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
August 26, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Announces $10.0 Million Registered Direct Offering
August 12, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board
August 05, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study
July 08, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets
June 28, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Receives Notice of Patent Allowance in China for NASH Treatment
June 16, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite To Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson
June 02, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite to Present at BIO Digital International Convention & Conduct One-on-One Meetings with Potential Partners on June 10-18, 2021
June 02, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Reports First Quarter 2021 Financial Results & Provides Clinical Update
May 27, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
May 27, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite to Present at Benzinga’s Global Small Cap Conference on May 13, 2021
May 06, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite’s Phase III Psoriasis Study Achieves 75% Enrollment; Top Line Results Expected Q4 2021
April 29, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Expands its Phase II COVID-19 Study to Europe
April 22, 2021
From
Can-Fite BioPharma Ltd
Via
Business Wire
Can-Fite Initiates Preclinical Studies Required by FDA and EMA for the Registration of its Two Lead Drug Candidates
April 20, 2021
From
Can-Fite BioPharma Ltd.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.